Company: INMB
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003354
Chunk: 1078

Company: Inmune Bio, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 14
Chunk 1078
---
1754
    
      us-gaap:ResearchAndDevelopmentExpenseMember

    2023-01-01
    2023-12-31

    0001711754
    
      country:AU

    2024-01-01
    2024-12-31

    0001711754
    
      country:AU

    2023-01-01
    2023-12-31

    0001711754
    
      inmb:ImmuneVenturesMember

    2024-01-01
    2024-12-31

    0001711754
    
      srt:ScenarioForecastMember

    2025-06-26
    2025-06-26

    0001711754
    
      inmb:MilestonePaymentPhaseOneInitiationMember

    2024-01-01
    2024-12-31

    0001711754
    
      inmb:MilestonePaymentPhaseTwoInitiationMember

    2024-01-01
    2024-12-31

    0001711754
    
      inmb:MilestonePaymentPhaseThreeInitiationMember

    2024-01-01
    2024-12-31

    0001711754
    
      inmb:MilestonePaymentNdaEmaFilingMember

    2024-01-01
    2024-12-31

    0001711754
    
      inmb:MilestonePaymentNdaEmaAwardedMember

    2024-01-01
    2024-12-31

    0001711754
    
      inmb:EachPhaseInitiationMember

    2024-01-01
    2024-12-31

    0001711754
    
      inmb:EachPhaseIIIInitiationMember

    2024-01-01
    2024-12-31

    0001711754
    
      us-gaap:TechnologyBasedIntangibleAssetsMember

    2024-01-01
    2024-12-31

    0001711754
    
      us-gaap:USTreasuryBillSecuritiesMember
      us-gaap:FairValueMeasurementsRecurringMember

    2024-12-31

    0001711754
    
      us